Gabapentin-induced myopathy in 2 patients on short daily hemodialysis

被引:8
作者
Lipson, J
Lavoie, S
Zimmerman, D
机构
[1] Ottawa Hosp, Kidney Res Ctr, Dept Med, Div Nephrol, Ottawa, ON, Canada
[2] Univ Ottawa, Ottawa, ON, Canada
关键词
gabapentin; hemodialysis (HD); myopathy; daily;
D O I
10.1053/j.ajkd.2005.02.024
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Gabapentin is an antlepileptic medication that also has been used for restless legs syndrome. The mechanism of action Is unknown. The most commonly reported adverse effects of this medication include somnolence, dizziness, ataxia, fatigue, nystagmus, and tremor. Myalgia has been reported in 2% of gabapentin users compared with 1.9% of patients in placebo-controlled add-on trials. Two patients on short daily hemodialysis therapy developed neuromuscular symptoms and an elevation In creatine kinase levels after starting gabapentin therapy. To our knowledge, this is the first case report of an increase in creatine kinase level after the administration of gabapentin. (c) 2005 by the National Kidney Foundation, Inc.
引用
收藏
页码:E100 / E104
页数:5
相关论文
共 16 条
  • [11] Effect of pergolide on restless legs and leg movements in sleep in uremic patients
    Pieta, J
    Millar, T
    Zacharias, J
    Fine, A
    Kryger, M
    [J]. SLEEP, 1998, 21 (06) : 617 - 622
  • [12] Statin-associated myopathy
    Thompson, PD
    Clarkson, P
    Karas, RH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (13): : 1681 - 1690
  • [13] A crossover study of gabapentin in treatment of restless legs syndrome among hemodialysis patients
    Thorp, ML
    Morris, CD
    Bagby, SP
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (01) : 104 - 108
  • [14] Walker SL, 1996, SLEEP, V19, P214
  • [15] Restless legs syndrome in end-stage renal disease
    Winkelman, JW
    Chertow, GM
    Lazarus, JM
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (03) : 372 - 378
  • [16] Long-term course of restless legs syndrome in dialysis patients after kidney transplantation
    Winkelmann, J
    Stautner, A
    Samtleben, W
    Trenkwalder, C
    [J]. MOVEMENT DISORDERS, 2002, 17 (05) : 1072 - 1076